What changedvs. the 10-Q for 2026 Q14 notable changesView full comparison
    • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. — Rewritten: Combination are limited and are paid by the Sponsor on our behalf and recorded against the Due from related party balance, which was $72,476 as of June 30, 2026. Transaction costs associated with the Business Combination, including legal, accounting and advisory fees incurred in…
    • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. — Rewritten: $3,073,108, partially offset by general and administrative costs of $121,962, professional fees of $140,000, and a loss on the change in fair value of warrant liability of $1,720,874. For the three months ended June 30, 2025 and for the period from April 29, 2025 (inception)…
    • Item 1. Condensed Financial Statements. — Rewritten: exercise price of $11.50 per share exceeded the $10.00 underlying share price used in the Company’s valuation framework at the reporting date, and accordingly they
    • Item 1. Condensed Financial Statements. — Rewritten: Q2 2026. Two peers included in the basket at March 31, 2026 no longer met the selection criteria and were excluded at June 30,